Skip to Content
Søg Menu

Overall survival in patients with advanced stage Hodgkin’s Lymphoma improves on Brentuximab Vedotin

Brentuximab Vedotin plus chemotherapy as first-line treatment improves the overall survival in patients suffering from stage III or IV Hodgkin’s Lymphoma. Get an update on the ECHELON-1 trial by investigator Stephen Ansell in this MEDtalk.

Stephen Ansell

Få adgang

Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.

Relateret indhold

Jason Westin

Potential for Targeted and Immune-Facing Therapies for Patients with CNS Lymphoma

/ Jason Westin
ASH23Lymfom Play the Video 01:08
Martin Hutchings

Opdaterede data viser fortsat komplet respons hos over 50% af patienter behandlet med glofitamab for r/r storcellet B-celle lymfom

/ Martin Hutchings
ASH23B-celle lymfomLymfom Play the Video 4:05
Mats Jerkeman

Key Updates in Mantle Cell Lymphoma from ASH 2023

/ Mats Jerkeman
ASH23Lymfom Play the Video 5:27
Martin Hutchings

Opmuntrende resultater for patienter med aggressiv lymfom

/ Martin Hutchings
ASH23Lymfom Play the Video 3:57

Half of Male Lymphoma Survivors Suffer from Erectile Dysfunction

/ Signe Micas Pedersen
LymfomLivskvalitet

No need for bone marrow biopsy of CNS lymphoma in PET-CT era

/ Jelena Jelicic / Karen Juul-Jensen
Lymfom
Anna Sureda Balari

Epcoritamab with Rituximab and Lenalidomide (R2) for Patients with High-Risk Follicular Lymphoma

/ Anna Sureda Balari
EHA23Lymfom Play the Video 6:24
Ryan Jacobs

News from EHA23 – A Promising Treatment Option for Follicular Lymphoma

/ Ryan Jacobs
EHA23Lymfom Play the Video 11:56
Eva Futtrup Maksten

Risk of Dementia in Older Patients Treated with Chemotherapy for Lymphoma

/ Eva Futtrup Maksten
EHA23LymfomDemens Play the Video 03:17
Back to top